Medication info
Crestet Tablet 10/10 mg (Ezetimibe, Rosuvastatin)

Crestet Tablet 10/10 mg (Ezetimibe, Rosuvastatin)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
Yellow oblong film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP×3]
Approval status
Active

MFDS item code 202004613 · Approved 2020.06.23 · Insurance code 656005560

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • decreased HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps reduce serum total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing the level of good cholesterol, HDL cholesterol. It is particularly used as an adjunctive therapy when the risk of atherosclerotic vascular disease due to hypercholesterolemia is high, or when adequate results are not achieved with non-pharmacological treatments such as dietary therapy. It is important to check for other underlying conditions or medication use before administration and to treat them if necessary. Additionally, lipid levels in the blood should be regularly monitored safely throughout the treatment process. This medication is more effective when accompanied by appropriate dietary adjustments and helps lower the risk of cardiovascular disease by improving blood lipid levels.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.

Precautions

This medication carries the risk of muscle complications, so if any severe muscle pain or weakness symptoms arise, consult a doctor immediately. Particularly in cases of severe infection, hypotension, post-surgery status, trauma, or severe metabolic or endocrine diseases, it may be necessary to temporarily stop or discontinue this medication. Patients allergic to the ingredients of this medication, those with liver disease, or those with muscle diseases should not take it. Additionally, people with severe kidney failure, pregnant or potentially pregnant women, and nursing mothers should not use this medication. Since this medication contains lactose, patients with lactose intolerance should not take it. Alcoholics or patients with a history of liver disease and those at high risk for muscle diseases should take this medication cautiously and require periodic blood tests and muscle condition checks. Side effects such as abnormal liver function, muscle pain, fatigue, headache, dyspepsia, edema, etc., can occur during the course of this medication, so severe symptoms should be reported to a doctor. If severe muscle pain or markedly increased muscle enzyme levels are detected in blood tests, the medication should be stopped immediately and consulting with medical personnel is necessary. This medication may interact with other medications, so it is important to inform your doctor or pharmacist if you are taking any other medications, especially anticoagulants, fibrates, certain antibiotics, and antifungals. This medication should not be used during pregnancy or breastfeeding, and women of childbearing age should use appropriate contraception while taking it. Safety and effectiveness have not been sufficiently established in children and the elderly, hence special caution is required. This medication can affect liver and kidney function, so patients with liver or kidney diseases should regularly undergo tests. There is no specific antidote in case of overdose, so appropriate treatment and supportive therapy based on symptoms should be administered. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

Nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated CPK, elevated AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood sugar, chest discomfort, dizziness, drowsiness, neurodegenerative disorder, postural dizziness, migraine, diabetes mellitus, depression, bronchitis, rhinitis, cystitis, dermatophyte infection of nails, soft tissue infection, fatty liver disease, liver impairment, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorder, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, chest pain, facial edema, unusual feeling, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, memory impairment, forgetfulness, amnesia, memory disorder, confusion, severe myasthenia, ocular myasthenia, elevated CK, chest pain, muscle cramp, gout, erectile dysfunction, fatigue, numbness, paresthesia, loss of appetite, abdominal distention, abnormal liver function tests, syncope, generalized pain, tremor, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorder, gastroesophageal reflux disease, tongue disorder, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival injection, renal failure, increased serum creatinine, elevated blood pressure, increased serum urea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow oblong film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.